Skip to main content
    V

    Vicarious Surgical Inc. (RBOT)

    Official site

    MEDICAL DEVICES

    $0.00
    +0.00 (+2900.00%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Vicarious Surgical Inc. (RBOT) Financials: Revenue, Profit and Cash Flow

    Updated Mar 31, 2026. Financial statements from company filings, amounts in US dollars.

    Vicarious Surgical reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$50.18M, operating cash flow was -$45.08M and free cash flow was -$45.21M. The quarter ended Mar 31, 2026 had revenue of $0 and net income of -$7.33M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $50.03M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019N/AN/AN/AN/AN/A
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Mar 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Research and development$33.60M$40.16M$47.58M$43.90M$22.06M$9.80M$7.48M
    Operating income-$50.03M-$66.56M-$80.67M-$80.08M-$38.22M-$12.98M-$9.78M
    Net income-$50.18M-$63.22M-$71.07M$5.16M-$35.21M-$12.88M-$9.31M
    EBITDA-$49.92M-$65.41M-$74.85M$5.11M-$34.80M-$12.83M-$9.68M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Revenue$0$0$0$0$0$2.09M$0$0$0$3.45M$0$0
    Gross profit$0-$291.00K$0$0$0-$542.00K$0$0$0-$525.00K$0$0
    Operating income-$7.50M-$9.26M-$11.50M-$13.52M-$15.75M-$14.98M-$17.75M-$17.71M-$16.11M-$15.54M-$21.35M-$21.46M
    Net income-$7.33M-$10.52M-$11.06M-$13.21M-$15.39M-$13.93M-$17.09M-$15.21M-$17.00M-$13.11M-$15.70M-$15.33M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $525.00K by $2.04M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$19.58M$67.72M$119.86M$140.29M$181.68M$17.79M$16.36M
    Current assets$11.58M$51.70M$100.95M$120.40M$178.37M$17.13M$15.73M
    Cash and equivalents$2.57M$9.74M$52.82M$116.21M$173.51M$16.87M$2.16M
    Total liabilities$9.74M$21.02M$21.89M$29.25M$98.59M$935.00K$733.00K
    Short-term debt$525.00K$0$1.05M$16.00K$647.00K$47.00K$47.00K
    Long-term debtN/AN/AN/AN/A$675.00K$0N/A
    Shareholder equity$9.84M$46.70M$97.97M$111.05M$83.09M$16.85M$15.63M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total assets$12.59M$19.58M$29.35M$40.89M$55.05M$67.72M$80.62M$93.35M$105.29M$119.86M$132.05M$104.53M
    Total liabilities$9.02M$9.74M$15.26M$17.83M$20.98M$21.02M$22.73M$21.49M$21.28M$21.89M$24.18M$28.84M
    Cash and equivalents$1.41M$2.57M$3.16M$3.91M$2.60M$9.74M$7.07M$20.25M$38.22M$52.82M$59.11M$32.81M
    Shareholder equity$3.57M$9.84M$14.09M$23.06M$34.08M$46.70M$57.88M$71.86M$84.01M$97.97M$107.87M$75.69M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$45.08M-$49.96M-$62.30M-$61.21M-$33.30M-$12.04M-$8.71M
    Capital expenditures$132.00K$180.00K$1.67M$5.35M$1.29M$120.00K$246.00K
    Free cash flow-$45.21M-$50.14M-$63.98M-$66.56M-$34.59M-$12.16M-$8.96M
    Share repurchasesN/AN/A$2.82M$300.00KN/AN/AN/A
    Investing cash flow$32.15M$6.86M-$45.78M-$5.35M-$1.29M$13.20M-$1.85M
    Financing cash flow$5.76M$8.00K$44.70M$9.14M$192.16M$13.52M$10.00M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Operating cash flow-$6.33M-$9.31M-$10.46M-$13.53M-$11.77M-$11.79M-$12.69M-$11.02M-$14.46M-$11.37M-$17.28M-$15.08M
    Capital expenditures$9.00K$10.00K$117.00KN/A$5.00K$195.00K$31.00K$6.00K$10.00K$1.04M$118.00K$208.00K
    Free cash flow-$6.33M-$9.32M-$10.58MN/A-$11.77M-$11.98M-$12.72M-$11.03M-$14.47M-$12.41M-$17.40M-$15.29M
    Last 12 quarters

    Frequently Asked Questions About RBOT

    What is Vicarious Surgical's annual revenue?

    Vicarious Surgical reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Vicarious Surgical profitable?

    No. Vicarious Surgical reported net income of -$50.18M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does RBOT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$45.08M minus capital expenditures of $132.00K produced free cash flow of -$45.21M.

    How much debt does Vicarious Surgical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $525.00K and cash and equivalents of $2.57M.